Arseus (EBR:RCUSA) Disclosure Of Received Notification, In Accordance With The Act Of 2 May 2007

Arseus (EBR:RCUSA) Waregem, 3 November 2008 - In accordance with the stipulations of article 29 of the Act of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Arseus informs that it had 964,358 voting rights (treasury shares) on 24 October 2008, after closing of Euronext Amsterdam/Brussels.

Based on this notification and earlier received notifications and the denominator of 31,195,121 (total number of voting rights), the structure of the shareholding of Arseus is as follows:

+------------------------------------------+ | Fortis Investment Management SA | 8.84% | |---------------------------------+--------| | Omega Pharma NV* | 24.04% | |---------------------------------+--------| | Couckinvest NV / Coucke* | 12.37% | |---------------------------------+--------| | Arseus NV (treasury shares) | 3.09% | |---------------------------------+--------| | Public | 51.66% | +------------------------------------------+

* related parties

The original notification forms are also available on the corporate website (www.arseus.com).

This is a translation of the Dutch press release; the Dutch press release prevails.

For further information: Constantijn van Rietschoten, Investor Relations Manager +31 6 536 91 585 (mobile) constantijn.van.rietschoten@arseus.com

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.



LINK: http://hugin.info/138311/R/1265555/278543.pdf

Arseus

http://www.arseus.com/

ISIN: BE0003874915

Stock Identifier: XBRU.RCUSA